1.15

10.58% 0.11

After Hours: 1.18 0.03 +2.61%

Shattuck Labs Inc (STTK)

Overview News Price History Option Chain Financials Discussions Forecast

Shattuck Labs Inc stock is traded at $1.15, with a volume of 424.98K. It is up +10.58% in the last 24 hours and up +3.60% over the past month. Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

Previous Close:

$1.04

Open:

$1.02

24h Volume:

424.98K

Relative Volume:

0.66

Market Cap:

$54.90M

Revenue:

$2.72M

Net Income/Loss:

$-85.08M

P/E Ratio:

-0.53

EPS:

-2.17

Net Cash Flow:

$-70.93M

1W Performance:

+0.88%

1M Performance:

+3.60%

6M Performance:

-72.39%

1Y Performance:

-82.17%

1-Day Range:

$1.02

$1.16

1-Week Range:

$1.02

$1.19

52-Week Range:

$0.94

$11.76

Shattuck Labs Inc Stock (STTK) Company Profile

Name

Shattuck Labs Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

512-900-4690

Address

500 W. 5TH STREET, AUSTIN

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

STTK's Discussions on Twitter

Compare STTK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STTK Shattuck Labs Inc	1.15	54.90M	2.72M	-85.08M	-70.93M	-1.93
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-02-24	Downgrade	Citigroup	Buy → Neutral
Oct-02-24	Downgrade	Needham	Buy → Hold
Oct-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Aug-31-22	Initiated	BTIG Research	Buy
Jun-01-22	Initiated	Citigroup	Buy
May-02-22	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Berenberg	Buy
Jan-11-21	Initiated	Evercore ISI	Outperform
Nov-03-20	Initiated	Citigroup	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Needham	Buy

View All

Shattuck Labs Inc Stock (STTK) Latest News

Dec 11, 2024

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online

Dec 11, 2024

MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World

Dec 11, 2024

Dec 10, 2024

STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com

Dec 10, 2024

Dec 07, 2024

Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat

Dec 07, 2024

Dec 06, 2024

Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com

Dec 06, 2024

Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com

Dec 06, 2024

Nov 26, 2024

GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World

Nov 26, 2024

Nov 25, 2024

Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan

Nov 25, 2024

Nov 24, 2024

Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St

Nov 24, 2024

Nov 22, 2024

Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada

Nov 22, 2024

Nov 21, 2024

Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India

Nov 21, 2024

Nov 20, 2024

Citigroup Downgrades Shattuck Labs (STTK) - MSN

Nov 20, 2024

Nov 19, 2024

Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 18, 2024

STTK (Shattuck Labs) Degree of Operating Leverage : -0.01 (As of Jun. 2024) - GuruFocus.com

Nov 15, 2024

Shattuck Labs' (STTK) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat

Nov 15, 2024

Shattuck Labs sees cash runway into 2027 - Yahoo Finance

Nov 15, 2024

Nov 14, 2024